Running Point Capital Advisors, LLC Eli Lilly & CO Transaction History
Running Point Capital Advisors, LLC
- $222 Million
- Q1 2024
A detailed history of Running Point Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Running Point Capital Advisors, LLC holds 1,880 shares of LLY stock, worth $1.7 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
1,880
Previous 1,026
83.24%
Holding current value
$1.7 Million
Previous $598,000
144.48%
% of portfolio
0.66%
Previous 0.29%
Shares
9 transactions
Others Institutions Holding LLY
# of Institutions
3,721Shares Held
738MCall Options Held
7.09MPut Options Held
7.24M-
Lilly Endowment Inc Indianapolis, IN98.9MShares$89.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$66 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$59.2 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$46.6 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$31.1 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $862B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...